We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In response to criticism surrounding the price of its EpiPen, Mylan plans to sell a generic version of its allergy treatment for half the price. Read More
Mylan is cutting out-of-pocket costs for its EpiPen after members of Congress and presidential hopeful Hillary Clinton lambasted the company for hiking the price of the emergency allergy therapy. Read More
The UK’s drug pricing watchdog has recommended reimbursement for Eli Lilly’s lung cancer drug Alimta and Pfizer’s leukemia therapy Bosulif at discounted prices. Read More
Pfizer is advancing talks to acquire the U.S. cancer drug company Medivation for close to $14 billion in an effort to boost its oncology portfolio. Read More